209 related articles for article (PubMed ID: 11714112)
21. Intrauterine exposure to diethylstilbestrol: long-term effects in humans.
Swan SH
APMIS; 2000 Dec; 108(12):793-804. PubMed ID: 11252812
[TBL] [Abstract][Full Text] [Related]
22. Epidemiological studies of the effects of diethylstilboestrol.
Vessey MP
IARC Sci Publ; 1989; (96):335-48. PubMed ID: 2680951
[TBL] [Abstract][Full Text] [Related]
23. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol.
Herbst AL; Anderson D
Semin Surg Oncol; 1990; 6(6):343-6. PubMed ID: 2263810
[TBL] [Abstract][Full Text] [Related]
24. Six years' experience with screening of a diethylstilbestrol-exposed population.
Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
[TBL] [Abstract][Full Text] [Related]
25. The development of cervical and vaginal adenosis as a result of diethylstilbestrol exposure in utero.
Laronda MM; Unno K; Butler LM; Kurita T
Differentiation; 2012 Oct; 84(3):252-60. PubMed ID: 22682699
[TBL] [Abstract][Full Text] [Related]
26. The effects in the human of diethylstilbestrol (DES) use during pregnancy.
Herbst AL
Princess Takamatsu Symp; 1987; 18():67-75. PubMed ID: 3506546
[TBL] [Abstract][Full Text] [Related]
27. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks.
Hanselaar A; van Loosbroek M; Schuurbiers O; Helmerhorst T; Bulten J; Bernhelm J
Cancer; 1997 Jun; 79(11):2229-36. PubMed ID: 9179071
[TBL] [Abstract][Full Text] [Related]
28. Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project.
Robboy SJ; Noller KL; O'Brien P; Kaufman RH; Townsend D; Barnes AB; Gundersen J; Lawrence WD; Bergstrahl E; McGorray S
JAMA; 1984 Dec; 252(21):2979-83. PubMed ID: 6502858
[TBL] [Abstract][Full Text] [Related]
29. Squamous cell dysplasia and carcinoma in situ of the cervix and vagina after prenatal exposure to diethylstilbestrol.
Robboy SJ; Keh PC; Nickerson RJ; Helmanis EK; Prat J; Szyfelbein WM; Taft PD; Barnes AB; Scully RE; Welch WR
Obstet Gynecol; 1978 May; 51(5):528-35. PubMed ID: 652199
[TBL] [Abstract][Full Text] [Related]
30. Identification and management of DES-exposed women.
Vieiralves-Wiltgen C; Engle VF
Nurse Pract; 1988 Nov; 13(11):15-6, 19-20, 22 passim. PubMed ID: 3231355
[TBL] [Abstract][Full Text] [Related]
31. Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation.
Titus-Ernstoff L; Troisi R; Hatch EE; Hyer M; Wise LA; Palmer JR; Kaufman R; Adam E; Noller K; Herbst AL; Strohsnitter W; Cole BF; Hartge P; Hoover RN
Epidemiology; 2008 Mar; 19(2):251-7. PubMed ID: 18223485
[TBL] [Abstract][Full Text] [Related]
32. Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol.
Camp EA; Coker AL; Troisi R; Robboy SJ; Noller KL; Goodman KJ; Titus-Ernstoff LT; Hatch EE; Herbst AL; Kaufman RH; Adam E
J Low Genit Tract Dis; 2008 Apr; 12(2):111-7. PubMed ID: 18369304
[TBL] [Abstract][Full Text] [Related]
33. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic].
van Dijck JA; Doorduijn Y; Bulten JH; Verloop J; Massuger LF; Kiemeney BA
Ned Tijdschr Geneeskd; 2009; 153():A366. PubMed ID: 19857300
[TBL] [Abstract][Full Text] [Related]
34. Estrogen Metabolism in Postmenopausal Women Exposed
Troisi R; Hatch EE; Palmer JR; Titus L; Sampson JN; Xu X; Hoover RN
Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1208-1213. PubMed ID: 30049842
[No Abstract] [Full Text] [Related]
35. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
Edelman DA
Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
[TBL] [Abstract][Full Text] [Related]
36. Vaginal and cervical squamous cell dysplasia in women exposed to diethylstilbestrol in utero.
Burke L; Antonioli D; Rosen S
Am J Obstet Gynecol; 1978 Nov; 132(5):537-44. PubMed ID: 717453
[TBL] [Abstract][Full Text] [Related]
37. Risk of clear-cell adenocarcinoma of the vagina and cervix among US women with potential exposure to diethylstilbestrol in utero.
White MC; Weir HK; Soman AV; Peipins LA; Thompson TD
Cancer Causes Control; 2022 Aug; 33(8):1121-1124. PubMed ID: 35767133
[TBL] [Abstract][Full Text] [Related]
38. Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring.
Kaufman RH; Adam E; Hatch EE; Noller K; Herbst AL; Palmer JR; Hoover RN
Obstet Gynecol; 2000 Oct; 96(4):483-9. PubMed ID: 11004345
[TBL] [Abstract][Full Text] [Related]
39. Cancer risk in DES daughters.
Verloop J; van Leeuwen FE; Helmerhorst TJ; van Boven HH; Rookus MA
Cancer Causes Control; 2010 Jul; 21(7):999-1007. PubMed ID: 20204493
[TBL] [Abstract][Full Text] [Related]
40. Diethylstilbestrol (DES) update: recommendations for the identification and management of DES-exposed individuals.
Hammes B; Laitman CJ
J Midwifery Womens Health; 2003; 48(1):19-29. PubMed ID: 12589302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
